MODERN ANTIPLATELET THERAPY OF ISCHEMIC HEART DISEASE PATIENTS WITH HIGH RISK OF THROMBOTIC EVENTS: DATA FROM EVIDENCE-BASED MEDICINE AND REAL PRACTICE
Aim. To study a rate of clopidogrel use in patients having indications for clopidogrel therapy according with up to date guidelines. Material and methods. Database of patients experienced acute myocardial infarction (MI) and database of patients experienced angiography because of stable ischemic hea...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Столичная издательская компания
2016-01-01
|
| Series: | Рациональная фармакотерапия в кардиологии |
| Subjects: | |
| Online Access: | https://www.rpcardio.online/jour/article/view/805 |
| _version_ | 1826949785552158720 |
|---|---|
| author | S. Yu. Martsevich M. L. Ginzburg A. M. Malysheva Yu. N. Polyanskaya T. G. Kheliya N. P. Kutishenko |
| author_facet | S. Yu. Martsevich M. L. Ginzburg A. M. Malysheva Yu. N. Polyanskaya T. G. Kheliya N. P. Kutishenko |
| author_sort | S. Yu. Martsevich |
| collection | DOAJ |
| description | Aim. To study a rate of clopidogrel use in patients having indications for clopidogrel therapy according with up to date guidelines. Material and methods. Database of patients experienced acute myocardial infarction (MI) and database of patients experienced angiography because of stable ischemic heart disease (IHD) were used to evaluate clopidogrel therapy implementation. Patients with acute MI (n=84) and patients with IHD after angioplasty (n=239) were interviewed. Results. Only 14 of 84 (16.6%) patients after acute MI and 112 of 239 (47%) patients after angioplasty were taken clopidogrel within 12 months. Conclusion. The majority of patients after MI and coronary angioplasty do not receive clopidogrel despite the need of dual antiplatelet agents therapy. |
| first_indexed | 2024-03-08T14:04:17Z |
| format | Article |
| id | doaj.art-b8f876492d364d00b47b940f26055cf5 |
| institution | Directory Open Access Journal |
| issn | 1819-6446 2225-3653 |
| language | English |
| last_indexed | 2025-02-17T22:20:12Z |
| publishDate | 2016-01-01 |
| publisher | Столичная издательская компания |
| record_format | Article |
| series | Рациональная фармакотерапия в кардиологии |
| spelling | doaj.art-b8f876492d364d00b47b940f26055cf52024-12-04T11:48:07ZengСтоличная издательская компанияРациональная фармакотерапия в кардиологии1819-64462225-36532016-01-017331932210.20996/1819-6446-2011-7-3-319-322804MODERN ANTIPLATELET THERAPY OF ISCHEMIC HEART DISEASE PATIENTS WITH HIGH RISK OF THROMBOTIC EVENTS: DATA FROM EVIDENCE-BASED MEDICINE AND REAL PRACTICES. Yu. Martsevich0M. L. Ginzburg1A. M. Malysheva2Yu. N. Polyanskaya3T. G. Kheliya4N. P. Kutishenko5State Research Center for Preventive Medicine I.M. Setchenov First Moscow State Medical UniversityLyubertsy District Hospital № 2State Research Center for Preventive MedicineState Research Center for Preventive MedicineState Research Center for Preventive MedicineState Research Center for Preventive MedicineAim. To study a rate of clopidogrel use in patients having indications for clopidogrel therapy according with up to date guidelines. Material and methods. Database of patients experienced acute myocardial infarction (MI) and database of patients experienced angiography because of stable ischemic heart disease (IHD) were used to evaluate clopidogrel therapy implementation. Patients with acute MI (n=84) and patients with IHD after angioplasty (n=239) were interviewed. Results. Only 14 of 84 (16.6%) patients after acute MI and 112 of 239 (47%) patients after angioplasty were taken clopidogrel within 12 months. Conclusion. The majority of patients after MI and coronary angioplasty do not receive clopidogrel despite the need of dual antiplatelet agents therapy.https://www.rpcardio.online/jour/article/view/805ischemic heart diseaseacute myocardial infarctioncoronary angioplastyclopidogrel |
| spellingShingle | S. Yu. Martsevich M. L. Ginzburg A. M. Malysheva Yu. N. Polyanskaya T. G. Kheliya N. P. Kutishenko MODERN ANTIPLATELET THERAPY OF ISCHEMIC HEART DISEASE PATIENTS WITH HIGH RISK OF THROMBOTIC EVENTS: DATA FROM EVIDENCE-BASED MEDICINE AND REAL PRACTICE Рациональная фармакотерапия в кардиологии ischemic heart disease acute myocardial infarction coronary angioplasty clopidogrel |
| title | MODERN ANTIPLATELET THERAPY OF ISCHEMIC HEART DISEASE PATIENTS WITH HIGH RISK OF THROMBOTIC EVENTS: DATA FROM EVIDENCE-BASED MEDICINE AND REAL PRACTICE |
| title_full | MODERN ANTIPLATELET THERAPY OF ISCHEMIC HEART DISEASE PATIENTS WITH HIGH RISK OF THROMBOTIC EVENTS: DATA FROM EVIDENCE-BASED MEDICINE AND REAL PRACTICE |
| title_fullStr | MODERN ANTIPLATELET THERAPY OF ISCHEMIC HEART DISEASE PATIENTS WITH HIGH RISK OF THROMBOTIC EVENTS: DATA FROM EVIDENCE-BASED MEDICINE AND REAL PRACTICE |
| title_full_unstemmed | MODERN ANTIPLATELET THERAPY OF ISCHEMIC HEART DISEASE PATIENTS WITH HIGH RISK OF THROMBOTIC EVENTS: DATA FROM EVIDENCE-BASED MEDICINE AND REAL PRACTICE |
| title_short | MODERN ANTIPLATELET THERAPY OF ISCHEMIC HEART DISEASE PATIENTS WITH HIGH RISK OF THROMBOTIC EVENTS: DATA FROM EVIDENCE-BASED MEDICINE AND REAL PRACTICE |
| title_sort | modern antiplatelet therapy of ischemic heart disease patients with high risk of thrombotic events data from evidence based medicine and real practice |
| topic | ischemic heart disease acute myocardial infarction coronary angioplasty clopidogrel |
| url | https://www.rpcardio.online/jour/article/view/805 |
| work_keys_str_mv | AT syumartsevich modernantiplatelettherapyofischemicheartdiseasepatientswithhighriskofthromboticeventsdatafromevidencebasedmedicineandrealpractice AT mlginzburg modernantiplatelettherapyofischemicheartdiseasepatientswithhighriskofthromboticeventsdatafromevidencebasedmedicineandrealpractice AT ammalysheva modernantiplatelettherapyofischemicheartdiseasepatientswithhighriskofthromboticeventsdatafromevidencebasedmedicineandrealpractice AT yunpolyanskaya modernantiplatelettherapyofischemicheartdiseasepatientswithhighriskofthromboticeventsdatafromevidencebasedmedicineandrealpractice AT tgkheliya modernantiplatelettherapyofischemicheartdiseasepatientswithhighriskofthromboticeventsdatafromevidencebasedmedicineandrealpractice AT npkutishenko modernantiplatelettherapyofischemicheartdiseasepatientswithhighriskofthromboticeventsdatafromevidencebasedmedicineandrealpractice |